2.71 USD
+0.02 (+0.74%)
2.6903 USD
-0.02 (-0.73%)
We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
Each year in the past 5 years GDRX had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 2.40%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
GDRX has a Return On Equity of 5.29%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
GDRX has a better Return On Invested Capital (5.73%) than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of GDRX (3.97%) is better than 88.57% of its industry peers.
GDRX's Profit Margin has declined in the last couple of years.
GDRX has a better Operating Margin (10.37%) than 85.71% of its industry peers.
GDRX's Operating Margin has declined in the last couple of years.
GDRX has a Gross Margin of 93.46%. This is amongst the best in the industry. GDRX outperforms 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.42, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GDRX (0.42) is comparable to the rest of the industry.
The Debt to FCF ratio of GDRX is 4.66, which is a neutral value as it means it would take GDRX, 4.66 years of fcf income to pay off all of its debts.
GDRX has a Debt to FCF ratio of 4.66. This is comparable to the rest of the industry: GDRX outperforms 60.00% of its industry peers.
GDRX has a Debt/Equity ratio of 0.81. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
The Debt to Equity ratio of GDRX (0.81) is worse than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.42 |
ROIC/WACC0.54
WACC10.7%
2.3 Liquidity
GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
GDRX has a Current ratio of 3.11. This is in the better half of the industry: GDRX outperforms 62.86% of its industry peers.
GDRX has a Quick Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.11, GDRX is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.37% over the past year.
Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
The Revenue has been growing slightly by 1.30% in the past year.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.32% on average per year.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.74, the valuation of GDRX can be described as very cheap.
GDRX's Price/Earnings ratio is rather cheap when compared to the industry. GDRX is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of GDRX to the average of the S&P500 Index (26.51), we can say GDRX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.09, the valuation of GDRX can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 6.09 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaper than 94.29% of the companies in the same industry.
GDRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GDRX is cheaper than 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.77 | ||
| EV/EBITDA | 6.92 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
GDRX's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y16.13%
EPS Next 3Y16.77%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.71
+0.02 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners50.74%
Inst Owner Change-2.53%
Ins Owners11.16%
Ins Owner Change3.08%
Market Cap919.86M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts76.19
Price Target4.98 (83.76%)
Short Float %8.84%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-4.58%
PT rev (3m)-8.19%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)-3.31%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 6.09 | ||
| P/S | 1.15 | ||
| P/FCF | 8.77 | ||
| P/OCF | 5.12 | ||
| P/B | 1.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.92 |
EPS(TTM)0.35
EY12.92%
EPS(NY)0.45
Fwd EY16.42%
FCF(TTM)0.31
FCFY11.41%
OCF(TTM)0.53
OCFY19.54%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.68
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.42 |
F-Score6
WACC10.7%
ROIC/WACC0.54
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
What is the valuation status for GDRX stock?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?
The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.